229) ultations, home delivery of medicines and patient education. |
230) CH with composite genotypes defines a patient group at high risk of leukemia pro |
231) language fMRI; in contrast, the epilepsy patient group map was bilateral. |
232) form how healthcare is delivered for this patient group. |
233) ing longitudinal studies and by comparing patient groups based on medication status, |
234) l health outcomes in different diagnostic patient groups were found. |
235) le is known about the care preferences of patient groups. |
236) No patient had CLL progression. |
237) In our series, one patient had a lateral canthus dehiscence. |
238) The patient had undergone gemcitabine-cysplati |
239) The suicide of a patient is a serious event that may consti |
240) The patient is now in good condition following |
241) sive PK exposures in the companion animal patient is often lacking. |
242) s that evaluated the effects of physician-patient language concordance on health out |
243) e evidence collated showed that physician-patient language concordance was associate |
244) tematic review assessed whether physician-patient language concordance, compared wit |
245) eraging a large dataset of administrative patient medical records, we apply our fram |
246) cal providers in decision-making based on patient's medical records. |
247) This paper proposes a new model for a patient-centred medical case report. |
248) Patient monitoring helps identify symptoms |
249) Remote patient monitoring (RPM) has the potential |
250) Sensor, wearable, and remote patient monitoring technologies are typica |
251) avioral outcomes (adherence to treatment, patient needs addressed), some psychosocia |
252) ion aids did not appear to be tailored to patient needs and preferences, nor were th |
253) mechanisms while more directly reflecting patient needs when evaluating the quality |
254) The 33-year-old patient of East-Asian origin exhibited lat |
255) llustrated report of a 87-year-old female patient of ours suffering from chronic lym |
256) ation gain, transparency, pragmatism, and patient-centeredness of the research. |
257) ues to identify clusters in the unlabeled patient or treatment data. |
258) However, identifying specific patient or treatment-related factors which |
259) ucational outcomes, including behavioral, patient-level, or systems-level changes. |
260) e reasons for this are discussed from the patient perspective, of which there is lit |
261) Lastly, from a provider and patient perspective, while both saw benefi |
add keyword